EMA PHARMACEUTICAL NEWS IN BRIEFS
March 1st, 2012
BY KEITH NUTHALL
THE EUROPEAN Medicines Agency (EMA) has released guidelines on the processing of renewals in its market authorisation procedure.
*It has released new advice on the structuring of information flows for applications for market authorisations and other agency regulatory requirements -
*The agency has published a paper on the pharmaceutical development of intravenous medicinal products containing active substances solubilised in micellar systems -
*It has unveiled an advisory paper for laboratories that analyse or evaluate clinical trial samples ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.